Cite
MLA Citation
Marc Puigvehí et al.. “Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort.” Liver international, vol. 39, 2019, pp. 90–97. http://access.bl.uk/ark:/81055/vdc_100076253661.0x00001c